Skip to main content

Table 3 Prevalence of use of different antihypertensive drug classes in patients with obesity of class I, II and III

From: Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy

 

β-blockers

ACEIs

ARBs

CCBs

Diuretics

α1 adrenergic blockers

Whole population (n = 129)

45 (34.9)

39 (30.2)

55 (42.9)

25 (19.4)

60 (46.9)

7 (5.4)

 Class I (n = 59)

13 (22.0)

25 (42.3)

23 (38.9)

16 (27.1)

26 (44.1)

1 (1.7)

 Class II (n = 34)

19 (55.9)

6 (17.6)

16 (47.1)

5 (14.7)

18 (52.9)

1 (2.9)

 Class III (n = 36)

13 (36.1)

8 (22.0)

16 (44.4)

4 (11.1)

16 (47.1)

5 (13.9)

Only antihypertensive (n = 104)

35 (33.7)

33 (31.7)

45 (43.3)

20 (18.3)

48 (46.2)

4 (3.7)

 Class I (n = 46)

10 (21.7)

18 (39.1)

20 (43.5)

12 (26.1)

21 (45.7)

1 (2.2)

 Class II (n = 29)

14 (48.3)

6 (20.7)

13 (44.8)

4 (13.8)

15 (51.7)

1 (3.4)

 Class III (n = 29)

11 (37.9)

9 (31.0)

12 (41.4)

4 (13.8)

12 (41.4)

2 (6.8)

  1. The numbers in parentheses represent the percentage of the total of the respective group